Description
The Department of the Army -- USAMRAA is soliciting applications for the fiscal year 2026 Vision Research Program (VRP) Clinical Trial Award (CTA). This award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of service-connected eye injury and visual dysfunction. Research must align with at least one of the FY26 VRP Focus Areas. Key elements of the award mechanism include the requirement for IND/IDE approval for interventions that require regulatory authorizations, demonstration of access to the proposed intervention and target subject population, and a preproposal submission requirement. The maximum allowable funding is $2.6 million for total costs, and the maximum period of performance is 3 years.
• The award requires a preproposal submission by July 28, 2026, and application submission by November 12, 2026.
• Applications must provide evidence of IND or IDE approval to be considered for funding.
• The award supports clinical trials that have the potential to yield significant advancements in the treatment or management of service-connected eye injury and visual dysfunction.
• Partnering Principal Investigator Option is not applicable to this award mechanism.
• The award may be used to support clinical research, but not preclinical studies or full-scale clinical trials.